WEST PALM BEACH, Fla., May 11, 2017 /PRNewswire/ -- Alliance Bio-Products, Inc. (Bio-Products), a subsidiary of Alliance BioEnergy Plus, Inc. (OTCQB: ALLM) today announced that the Company has selected New York City-based Porter, LeVay & Rose, Inc. (PLR) as its Firm of Record for investor relations services supporting the Company's key growth initiatives.
PLR will support the Company as it continues to identify accredited investors for the purchase of a bioethanol plant in Southeast Florida and expansion of the Company's cellulose to sugar (CTS) production capacity. PLR will seek to generate interest from investors in the Company's Regulation D (506(c)) offering and guide Alliance Bio-Product's communications, providing capital market strategies.
"We look forward to working with the team at Porter, LeVay & Rose as we continue to connect with investors who are interested in being a part of a cleaner low-cost and environmentally responsible solution for biofuel," said Daniel de Liege, chairman of Alliance Bio-Products. "By partnering with PLR, a firm with strong connections, key contacts, and a deep understanding of messaging that will resonate with investors and shareholders, we feel confident in our efforts to secure funding for the next stages of our company expansion."
"We are thrilled to work with Alliance Bio-Products during this period of growth and expansion for the company, the technology and the bioethanol industry as a whole," said Michael Porter, President of Porter, LeVay & Rose. "The company and its CTS technology provide the bioethanol market with a new opportunity to produce low-cost, high-efficiency waste-based cellulosic ethanol. We look forward to helping the company reach key business expansion goal through connecting them with investors who share the same clean fuel passions."
About Alliance Bio-Products, Inc.
Alliance Bio-Products, Inc. was formed as a special purpose wholly-owned subsidiary of Alliance BioEnergy Plus, Inc. ("ALLM") to own and operate Bioethanol plants in the United States.
Utilizing ALLM's patented CTS process Alliance intends to retrofit existing ethanol plants with the mechnocatalytic cellulosic conversion process, transforming them into profitable renewable energy centers that are carbon neutral, waste free and protecting our delicate environment while providing energy and high value co-products. The CTS process enjoys a family of patents centered around the main U.S. patent # 8,062,428. 2032.
Information in this document constitute forward-looking statements or statements which may be deemed or construed to be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The risks, uncertainties and other factors are more fully discussed in the Company's filings with the U.S. Securities and Exchange Commission. All forward-looking statements attributable to Alliance BioEnergy Plus, Inc herein are expressly qualified in their entirety by the above-mentioned cautionary statement. Alliance BioEnergy Plus, Inc. disclaims any obligation to update forward-looking statements contained in this estimate, except as may be required by law.
Media contact:
Kate Caruso-Sharpe
FischTank Marketing and PR
[email protected]
IR Contact:
Michale Porter
Marlon Nurse
Porter, LeVay & Rose Inc.
7 Penn Plaza
New York, NY 10001
212-564-4700
SOURCE Alliance Bio-Products, Inc.
Share this article